MA57032A1 - Utilisation de beige cas9 issu de bactérie pasteurella pneumotropica - Google Patents

Utilisation de beige cas9 issu de bactérie pasteurella pneumotropica

Info

Publication number
MA57032A1
MA57032A1 MA57032A MA57032A MA57032A1 MA 57032 A1 MA57032 A1 MA 57032A1 MA 57032 A MA57032 A MA 57032A MA 57032 A MA57032 A MA 57032A MA 57032 A1 MA57032 A1 MA 57032A1
Authority
MA
Morocco
Prior art keywords
cas9
cell
beige
bacteria
crispr
Prior art date
Application number
MA57032A
Other languages
English (en)
Other versions
MA57032B2 (fr
Inventor
Timofey Aleksandrovich Nemankin
Roman Alekseevich Ivanov
Pavel Andreevich Iakovlev
Anna Konstantinovna Vladimirova
Dmitry Valentinovich Morozov
Sergey Anatolievich Lukyanov
Konstantin Viktorovich Severinov
Arina Vitalevna Anikina
Mariia Aleksandrovna Shchemeleva
Alexey Konstantinovich Misorin
Dmitry Borisovich Staroverov
Anna Valentinovna Evstrateva
Original Assignee
Biocad Joint Stock Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocad Joint Stock Co filed Critical Biocad Joint Stock Co
Publication of MA57032A1 publication Critical patent/MA57032A1/fr
Publication of MA57032B2 publication Critical patent/MA57032B2/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La présente invention concerne une nouvelle nucléase bactérienne du système crispr-cas9 à partir de la bactérie p. Pneumotropica, ainsi que son utilisation pour former des ruptures strictement spécifiques à deux brins dans la molécule d'adn. Cette nucléase possède des propriétés inhabituelles et peut être utilisée afin de modifier la séquence de l'adn génomique dans la cellule d'un organisme monocellulaire ou pluricellulaire il est ainsi possible d'améliorer l'universalité de systèmes disponibles crispr-cas9, ce qui permet d'utiliser différentes variantes de nucléases cas9 pour découper l'adn génomique ou plasmidique dans divers organismes et dans une grande quantité de sites spécifiques et/ou dans diverses conditions.
MA57032A 2019-11-11 2020-07-02 Utilisation de beige cas9 issu de bactérie pasteurella pneumotropica MA57032B2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2019136164A RU2724470C1 (ru) 2019-11-11 2019-11-11 Применение cas9 белка из бактерии pasteurella pneumotropica для модификации геномной днк в клетках
PCT/RU2020/050145 WO2021096391A1 (fr) 2019-11-11 2020-07-02 Utilisation de beige cas9 issu de bactérie pasteurella pneumotropica

Publications (2)

Publication Number Publication Date
MA57032A1 true MA57032A1 (fr) 2023-01-31
MA57032B2 MA57032B2 (fr) 2024-11-29

Family

ID=71136150

Family Applications (1)

Application Number Title Priority Date Filing Date
MA57032A MA57032B2 (fr) 2019-11-11 2020-07-02 Utilisation de beige cas9 issu de bactérie pasteurella pneumotropica

Country Status (17)

Country Link
US (1) US20220403369A1 (fr)
EP (1) EP4056705A4 (fr)
JP (1) JP7708752B2 (fr)
KR (1) KR20220145324A (fr)
CN (1) CN115397995B (fr)
AU (1) AU2020384851A1 (fr)
BR (1) BR112022009148A2 (fr)
CA (1) CA3157898A1 (fr)
CL (1) CL2022001220A1 (fr)
CO (1) CO2022006156A2 (fr)
MA (1) MA57032B2 (fr)
MX (1) MX2022005685A (fr)
PE (1) PE20230035A1 (fr)
PH (1) PH12022551155A1 (fr)
RU (1) RU2724470C1 (fr)
WO (1) WO2021096391A1 (fr)
ZA (1) ZA202205208B (fr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019165168A1 (fr) * 2018-02-23 2019-08-29 Pioneer Hi-Bred International, Inc. Nouveaux orthologues de cas9
RU2734432C1 (ru) * 2019-04-23 2020-10-16 Закрытое Акционерное Общество "Биокад" Моноклональное антитело, которое специфически связывается с GITR
BR112022017713A2 (pt) * 2020-03-04 2022-11-16 Flagship Pioneering Innovations Vi Llc Métodos e composições para modular um genoma

Also Published As

Publication number Publication date
MA57032B2 (fr) 2024-11-29
PE20230035A1 (es) 2023-01-10
CA3157898A1 (fr) 2021-05-20
CL2022001220A1 (es) 2023-01-06
JP7708752B2 (ja) 2025-07-15
PH12022551155A1 (en) 2023-10-02
CN115397995B (zh) 2025-04-11
ZA202205208B (en) 2023-04-26
MX2022005685A (es) 2022-07-27
CN115397995A (zh) 2022-11-25
RU2724470C1 (ru) 2020-06-23
EP4056705A1 (fr) 2022-09-14
US20220403369A1 (en) 2022-12-22
BR112022009148A2 (pt) 2023-05-02
KR20220145324A (ko) 2022-10-28
AU2020384851A1 (en) 2022-12-01
JP2023501524A (ja) 2023-01-18
WO2021096391A1 (fr) 2021-05-20
EP4056705A4 (fr) 2023-12-27
CO2022006156A2 (es) 2023-01-26

Similar Documents

Publication Publication Date Title
MA55390B1 (fr) Dispositif pour découper l'adn à base de la protéine cas9 à partir de la bactérie pasteurella pneumotropica
Jarraud et al. Relationships between Staphylococcus aureus genetic background, virulence factors, agr groups (alleles), and human disease
Voyich et al. The SaeR/S gene regulatory system is essential for innate immune evasion by Staphylococcus aureus
Sforza et al. Food analysis and food authentication by peptide nucleic acid (PNA)-based technologies
MA53577B1 (fr) Moyen de découpage d'adn à base de la protéine cas9 sur la base d'une bactérie à valeur biotechnologique clostridium cellulolyticum
MA53578A1 (fr) Dispositif pour découper l'adn à base de la protéine cas9 à partir de defluviimonas sp.
Freire-Benéitez et al. Candida albicans repetitive elements display epigenetic diversity and plasticity
Augagneur et al. Analysis of the CodY RNome reveals RsaD as a stress‐responsive riboregulator of overflow metabolism in Staphylococcus aureus
Hoang et al. Reconstruction of chromosome rearrangements between the two most ancestral duckweed species Spirodela polyrhiza and S. intermedia
MA57032A1 (fr) Utilisation de beige cas9 issu de bactérie pasteurella pneumotropica
Ouellet et al. Pseudomonas aeruginosa isolates from dental unit waterlines can be divided in two distinct groups, including one displaying phenotypes similar to isolates from cystic fibrosis patients
Chellaiah et al. High fluoride resistance and virulence profile of environmental Pseudomonas isolated from water sources
Farisa Banu et al. Marine bacterial DNase curtails virulence and disrupts biofilms of Candida albicans and non-albicans Candida species
Watanasrisin et al. Identification and characterization of Candida utilis multidrug efflux transporter Cu Cdr1p
Dereeper et al. Naegleria genus pangenome reveals new structural and functional insights into the versatility of these free-living amoebae
Feng et al. Null mutations of group A Streptococcus orphan kinase RocA: selection in mouse infection and comparison with CovS mutations in alteration of in vitro and in vivo protease SpeB expression and virulence
Sarang et al. Amyloid protein produced by B. cereus CR4 possesses bioflocculant activity and has potential application in microalgae harvest
Vervaeren et al. Quantification of an Eikelboom type 021N bulking event with fluorescence in situ hybridization and real-time PCR
Latka et al. Genome sequence of a clinical isolate of dermatophyte, Trichophyton rubrum from India
Chen et al. Eight SNVs in NF-κB pathway genes and their different performances between subclinical mastitis and mixed Chinese Holstein cows
Zhang et al. Polymorphism analysis of virulence-related genes among Candida tropicalis isolates
Eriksson et al. Association between Legionella species and humic substances during early summer in the northern Baltic Sea
Nielsen et al. ATXN2 with intermediate-length CAG/CAA repeats does not seem to be a risk factor in hereditary spastic paraplegia
Salman et al. CRISPR manipulation of age-related macular degeneration haplotypes in the complement system: potential future therapeutic applications/avenues
CN102199669B (zh) 辅助检测ndm-1基因的专用引物及其应用